Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cansino Biologics Inc
(OP:
CASBF
)
2.100
UNCHANGED
Last Price
Updated: 11:28 AM EDT, Apr 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6
Open
2.100
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
2.100
Today's Range
2.100 - 2.100
52wk Range
1.860 - 4.800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...
Via
Talk Markets
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
November 02, 2022
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.
Via
InvestorPlace
Performance
YTD
-21.50%
-21.50%
1 Month
+12.90%
+12.90%
3 Month
-6.04%
-6.04%
6 Month
-28.08%
-28.08%
1 Year
-55.41%
-55.41%
More News
Read More
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
May 28, 2022
Via
Talk Markets
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
December 11, 2021
Via
Talk Markets
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
April 24, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.